Bile acid modulators in discovery: Identifying cholestasis candidates with the best chance of success
Publication: Pharmaceutical Technology Focus
India’s only GLP-certified viral testing and clearance services
Syngene has India’s only GLP-certified viral testing facility that offers comprehensive viral safety solutions for your biologics program. Whether it’s studies supporting applications for Phase I, Phase III, or marketing authorizations, we have consistently delivered them with responsibility and unwavering commitment. At Syngene, viral safety is non-negotiable. Delivering safe and high-quality drugs to patients is […]
The rise of ADCs in oncology: how antibody drug conjugate therapies deliver precision
Understand antibody drug conjugate science, bioconjugation, and manufacturing controls that shape targeted therapy for cancer. Read the article today.
Tech transfer in CDMOs: avoiding the scale-up trap
Tech transfer sounds like a handover, but in a CDMO, it is a stress test. A process that behaves in a bench hood can shift when it meets plant-scale mixing, utilities, sampling routines, and tighter execution windows.
How AI is Reshaping CRDMOs: Use Cases and Results from Discovery to Manufacturing
Process analytical technology in CRDMOs uses AI to improve quality, speed tech transfer, and scale mRNA manufacturing. Read the full article.
Self-amplifying RNA: the next chapter in mRNA therapeutics
Self-amplifying RNA (saRNA) is emerging as the next wave in mRNA-based therapeutics, building on the achievements of first-generation mRNA vaccines and treatments.
GLP-1 Drugs Now Stand at the Centre of a Multi-Disease Treatment Revolution
Publication: Pharmaceutical Technology Focus
Green chemistry principles for a sustainable future in pharma
Green chemistry principles have moved from being a “nice to have” idea to a practical framework that shapes how molecules are discovered, developed and manufactured.
Integrated Drug Discovery: why expertise matters
See how chemistry, biology, DMPK, and DMTA expertise with a trusted preclinical CRO make integrated drug discovery faster and more reliable. Read now.
A step-by-step guide for conducting safe and successful bile duct cannulated PK studies
In recent years, the biopharmaceutical industry has increasingly focused on reducing animal testing when conducting safety and efficacy studies for new drugs. Ethical considerations, regulatory guidelines, and advancements in alternative testing methods like artificial intelligence have driven this shift.